American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead: Does the total consumption model apply to cannabis use?

Lead: Does the total consumption model apply to cannabis use?

Thursday 12th March 2026

Explore cannabis use trends in Sweden, overdose prevention centres in NYC, and opioid treatment strategies in this engaging episode.
7 minutes
Informative
Educational
Supportive
Eye-opening
Honest

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Cannabis Use and the Total Consumption Model: A Swedish Study

Episode Overview

  • Cannabis use among Swedish adolescents aligns with the total consumption model.
  • Overdose prevention centres have minimal impact on local businesses.
  • Novel induction strategies improve fentanyl-related opioid treatment.
  • Removing prior authorisation boosts buprenorphine access in Kentucky.
  • Alcohol use trajectories highlight risks of transitioning to dependence.
"Increases in mean frequency use were associated with a higher prevalence of high-frequency users."
What drives someone to seek a life without alcohol? In this episode of 'This Week in Addiction Medicine from ASAM', the discussion pivots to whether the total consumption model applies to cannabis use, particularly among adolescents in Sweden. The episode takes a closer look at a cross-sectional study that evaluates cannabis usage frequency and its implications. You'll hear about how increased average usage links to a rise in high-frequency users, echoing the predictions of the total consumption model.
But that's not all! The episode also explores the impact of overdose prevention centres on local economies in New York City, revealing that these centres might not be as disruptive as some feared. For those intrigued by opioid addiction treatment, there's an enlightening discussion on novel induction strategies for fentanyl-related disorders, emphasising the effectiveness of different buprenorphine dosing approaches. The hosts also touch on how removing prior authorisation requirements for buprenorphine in Kentucky significantly improved access for Medicaid enrollees.
As always, the podcast wraps up with insights into alcohol use trajectories and ketamine-related health risks, offering a comprehensive overview of current addiction medicine trends. So, if you're curious about the complexities of addiction and the latest research shaping treatment and policy, this episode is a must-listen. How do these findings challenge or reinforce your views on addiction treatment?
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2026 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.